FDA

Moderna Files for FDA Authorization for COVID-19 Vaccine Use in Teens

If cleared by the FDA, Moderna will become the second Covid-19 vaccine available in the U.S. for teens under 18 along with Pfizer-BioNTech's vaccine

•

NBCUniversal Media, LLC Moderna filed on Tuesday to request full FDA approval of its coronavirus vaccine, which was granted emergency use authorization in December.

Moderna on Thursday filed for emergency use authorization from the Food and Drug Administration to use its COVID-19 vaccine in adolescents ages 12 to 17, NBC News reports.

If cleared by the FDA, it will become the second Covid-19 vaccine available in the United States for teens under 18 along with Pfizer-BioNTech's vaccine, which was authorized for adolescents ages 12 to 15 in May.

Watch NBC Bay Area News 📺 Streaming free 24/7

Moderna said in May that results from its clinical trial among children ages 12 to 17 showed its two-dose mRNA vaccine to be safe and highly effective. The trial included more than 3,700 participants.

Moderna's vaccine for adults 18 and older has been administered in the U.S. since December.

Read the full story on NBCNews.com

Get a weekly recap of the latest San Francisco Bay Area housing news. Sign up for NBC Bay Area’s Housing Deconstructed newsletter.

This article tagged under:

FDA
Exit mobile version